Nidal Huniti

Nidal Huniti is an accomplished professional in the field of clinical pharmacology and drug development, currently serving as Associate Vice President at Eli Lilly and Company since October 2025, as well as an Adjunct Professor at the University of Michigan - School of Pharmacy since May 2022. Previously, Nidal held key leadership positions at Verve Therapeutics, Zentalis Pharmaceuticals, A2PG, Regeneron, and AstraZeneca, culminating in roles such as Vice President, Clinical Pharmacology & Pharmacometrics and Head of Quantitative Clinical Pharmacology. Nidal's extensive experience encompasses a strong focus on pharmacokinetics and pharmacodynamics, supported by a PhD and MSc from the University of Iowa.